SLC6A3 and Parkinson disease: The presynaptic dopaminergic system is affected by MSA pathology in a similar way to Lewy body pathology so that, while 18F-dopa PET, VMAT2, and DAT imaging can separate PD and MSA from healthy controls, they cannot reliably discriminate these 2 parkinsonian conditions [123].